Department of Chemical and Biotechnological Engineering, Université de Sherbrooke, 2500 boul. de l'Université, Sherbrooke, Québec J1K 2R1, Canada; Canada Research Chair in Cell-Biomaterial Biohybrid Systems Department of Chemical and Biotechnological Engineering, Université de Sherbrooke, 2500 boul. de l'Université, Sherbrooke, Québec J1K 2R1, Canada.
Department of Chemical and Biotechnological Engineering, Université de Sherbrooke, 2500 boul. de l'Université, Sherbrooke, Québec J1K 2R1, Canada.
J Control Release. 2014 May 28;182:73-82. doi: 10.1016/j.jconrel.2014.03.008. Epub 2014 Mar 15.
Type I collagen is one of the most widely used materials for drug delivery in tissue repair. It is the reference carrier for delivering growth factors like bone morphogenetic proteins (BMPs such as BMP-2 and BMP-7) for bone repair. Since BMPs are expensive to produce, we have developed a peptide derived from BMP-9 (pBMP-9) that is 300 times less expensive than the entire protein while still promoting osteogenic differentiation. We have now evaluated the effects of the collagen concentration and the initial pBMP-9 load on peptide release. We then developed a model of pBMP-9 release kinetics by finite differences using a system based on Fick's second law in which the interactions between the peptide and collagen fibers are assumed to follow Langmuir adsorption kinetics. The Langmuir isotherms suggest that the structure of the collagen gel influences the strength of its electrostatic interaction with the peptide, since increasing the collagen concentration decreased the affinity of pBMP-9 for the collagen. The resulting model of the mechanism accurately reflects the experimental data and the parameters estimated indicate that the diffusivities with the different collagen concentrations are similar, whereas the mass transfer coefficient increases with the collagen concentration. The results also indicate that perfect sink conditions cannot be assumed and suggest the presence of an optimal collagen concentration. Finally, we have correlated our conclusions with the differences in collagen fiber organization observed by transmission electron microscopy.
I 型胶原蛋白是组织修复中应用最广泛的药物递送材料之一。它是递送骨形态发生蛋白(如 BMP-2 和 BMP-7 等)等生长因子的参考载体,用于骨修复。由于 BMP 的生产成本很高,我们开发了一种源自 BMP-9 的肽(pBMP-9),其价格比完整蛋白便宜 300 倍,但仍能促进成骨分化。我们现在评估了胶原蛋白浓度和初始 pBMP-9 负载对肽释放的影响。然后,我们使用基于 Fick 第二定律的系统,通过有限差分法开发了 pBMP-9 释放动力学模型,假设肽与胶原纤维之间的相互作用遵循 Langmuir 吸附动力学。Langmuir 等温线表明,胶原凝胶的结构会影响其与肽之间静电相互作用的强度,因为增加胶原浓度会降低 pBMP-9 与胶原的亲和力。该机制的所得模型准确反映了实验数据,并且估计的参数表明,具有不同胶原浓度的扩散率相似,而质量转移系数随胶原浓度增加而增加。结果还表明,不能假设完全的吸收条件,并表明存在最佳的胶原浓度。最后,我们将我们的结论与透射电子显微镜观察到的胶原纤维组织差异相关联。